辐照血液临床应用中国专家共识  

Chinese expert consensus on clinical application of irradiated blood

作　　者：辐照血液临床应用中国专家共识编写组 林洁[2] 庄远[2] 于洋 Writing Group of Chinese Expert Consensus on Clinical Application of Irradiated Blood

机构地区：[1]不详 [2]解放军总医院第一医学中心

出　　处：《中国输血杂志》2023年第9期757-766,共10页Chinese Journal of Blood Transfusion

摘　　要：输血相关移植物抗宿主病(TA-GVHD)是1种严重的输血不良反应,输注辐照血液是预防TA-GVHD最为有效的方法。我国在辐照血液的应用上存在发展缓慢、认识不足、应用不规范等问题。本共识由国内输血医学、血液病学及儿科学领域专家进行深入探讨后完成。共识主要对辐照血液相关技术要点和临床应用做出推荐,并提出23条推荐意见。本共识旨在规范并促进辐照血液的合理应用,以期最大程度降低受血者TA-GVHD的发生风险,为今后制定更具规范性和指导性的指南奠定基础。Transfusion associated graft versus host disease(TA-GVHD)is a serious transfusion adverse reaction.It is widely believed that transfusion of irradiated blood is the most effective method to prevent TA-GVHD.There are some problems in the application of irradiated blood in China,such as slow development,insufficient understanding,and non-standard application.This consensus was completed after in-depth discussion by experts in the fields of transfusion medicine,hematology,and pediatrics in China.The Writing Group mainly discuss key technical points and clinical applications related to rradiated blood,and proposes 23 related recommendations.This consensus aims to standardize and promote the rational use of irradiated blood,minimize the risk of TA-GVHD in recipients and lay the foundation for developing more standardized guidelines in the future.

关 键 词：输血相关移植物抗宿主病 辐照血液 专家共识 

分 类 号：R457.1[医药卫生—治疗学]